Filgrastim biosimilar (Qilu Pharmaceutical)

非格司亭生物类似药（齐鲁制药）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Qilu Pharmaceutical)

Drug Alias Name非格司亭生物仿制药（齐鲁制药）Recombinant human granulocyte colony-stimulating factor (Qilu Pharmaceutical)rhG-CSF (Qilu Pharmaceutical)重组人粒细胞刺激因子（齐鲁制药）瑞白

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaNeutropenia

Original Approved Country/TerritoryMainland China

Original Approved Date1999/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesQilu Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesQilu Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02